CARGO Therapeutics, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CARGO Therapeutics, Inc. Common Stock generated cash of -$81,164,000, which is less than the previous year. Cash used in financing activities reached the amount of $494,583,000 last year. Net change in cash is therefore $404,427,000.
Cash Flow
| 2021 | -4.94M | -442K | 5.41M |
|---|---|---|---|
| 2022 | -29.07M | -3.28M | 34.18M |
| 2023 | -81.16M | -8.99M | 494.58M |
CRGX Cash Flow Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Cash at beginning of period | 1.87M | 41K | 11K |
Operating activities | |||
Net income | -98.14M | -40.95M | -5.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 3.69M | 1.44M | 147K |
Stock-based compensation expense | 3.32M | 297K | 507K |
| Deferred income tax benefit | 3.32M | 297K | 507K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 757K | 2.81M | 332K |
Cash generated by operating activities | -81.16M | -29.07M | -4.94M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -8.27M | -3.28M | -442K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -8.99M | -3.28M | -442K |
Financing activities | |||
Common Stock Issued | 296.60M | 5.73M | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 3.49M | 28.45M | 0 |
Cash used in financing activities | 494.58M | 34.18M | 5.41M |
Net Change In Cash | 404.42M | 1.83M | 30K |
Cash at end of period | 406.29M | 1.87M | 41K |
| Data source |